BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ASCEND Therapeutics, Inc. Presents Results Of Phase 2 Clinical Trial For Cyclic Breast Pain; Company's Transdermal 4-OHT Therapy Was Well Tolerated And Reduced Breast Pain In Clinical Trial


10/19/2005 5:10:14 PM

HERNDON, Va.--(BUSINESS WIRE)--May 11, 2005--ASCEND Therapeutics, a leading research and development company of pharmaceutical transdermal therapies for the treatment of chronic conditions, today announced that researchers presented findings regarding the company's 4-hydroxytamoxifen (4-OHT) gel during the 53rd Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG) at the Moscone Center in San Francisco. A poster presentation at ACOG offered data on the safety and efficacy of ASCEND Therapeutics' 4-OHT gel in patients with menstrual-cycle related mastalgia. The Phase 2 study, which was a placebo-controlled, double-blind, dose-ranging, and randomized study, indicated that the investigational transdermal 4-OHT gel, if approved by the FDA, may represent a new way to treat cyclic breast pain, also called cyclic mastalgia.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES